A Concise Review of Recent Advancements in Carbon Nanotubes for Aerospace Applications.

Carbon nanotubes (CNTs) have attracted significant attention in the scientific community and in the industrial environment due to their unique structure and remarkable properties, including mechanical strength, thermal stability, electrical conductivity, and chemical inertness. Despite their potential, large-scale applications have been limited by challenges such as high production costs and catalyst contamination. In aerospace applications, CNTs have demonstrated considerable promise either in the form of thin layers or as reinforcements in polymer and metal matrices, where they enhance mechanical, thermal, and electromagnetic performance in lightweight composites.

A Comprehensive Review of Electromagnetic Interference Shielding Composite Materials.

The interaction between matter and microwaves assumes critical significance due to the ubiquity of wireless communication technology. The selective shielding of microwaves represents the only way to achieve the control on crucial technological sectors. The implementation of microwave shielding ensures the proper functioning of electronic devices.

Low-Cost Carbon Fillers to Improve Mechanical Properties and Conductivity of Epoxy Composites.

In recent years, low-cost carbons derived from recycled materials have been gaining attention for their potentials as filler in composites and in other applications. The electrical and mechanical properties of polymer composites can be tuned using different percentages and different kind of fillers: either low-cost (e.g.

Association between major mood disorders and the hypocretin receptor 1 gene.

Background: Recent studies suggested a role for hypocretins in the neurobiology of Major Mood Disorders (MMD). The purpose of this study was to investigate hypocretin involvement in MMD evaluating whether particular alleles or genotypes of the hypocretin pathway genes (HCRT, HCRTR1 and HCRTR2) would modify the occurrence and clinical features of the disease.

Methods: We selected for the study 229 MMD patients and 259 healthy age-, sex- and ethnicity-matched controls.

Neuroendocrine (HPA axis) and clinical correlates during fluvoxamine and amitriptyline treatment.

The effect of amitriptyline on hypothalamic-pituitary-adrenocortical (HPA) axis activity was compared with that of fluvoxamine in 38 patients suffering from DMS-IV major depressive disorder. Basal plasma adrenocorticotropic hormone and cortisol levels were determined in the so-called "observation window" of an hour (08:00-09:00 h), and cortisol levels were determined again at 20:00 h. Clinical and biochemical assessments were performed before therapy (T0), at day 14 (T14), and at day 42 (T42) of the course of antidepressant treatment.